Skip to content

Clinical trials

Phase 4 Wet Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wet Macular Degeneration Phase: Phase 4 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20123
20132
20143
20161
20172
20214
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Aier School of Ophthalmology, Central South University1
Barcelona Macula Foundation1
Bayer1
Faculty Hospital Kralovske Vinohrady1
Medical University of Vienna1
Rishi Singh1
Seoul National University Hospital1
Tennessee Retina1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wet Macular Degeneration16
Macular Degeneration8
Geographic Atrophy5
Vision Disorders5
Choroidal Neovascularization4
Retinal Degeneration2
Eye Diseases1
Neovascularization, Pathologic1
Polypoidal Choroidal Vasculopathy1
Retinal Detachment1

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.